← SynDRA
ELUBRIXIN
SynDRA canonical compound SYN0034168 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CXCR2 |
|---|
| Mechanism of action | cc chemokine receptor antagonist |
|---|
| Indication | cystic fibrosis |
|---|
| Disease area | pulmonary |
|---|
All known targets
Mechanisms of action (all sources)
- CXCR2 ANTAGONIST
- Interleukin-8 receptor B antagonist
- cc chemokine receptor antagonist
Cross-references
Synonyms
- Elubrixine
- Elubrixina
- SB-656933
- SB-656933-AAF
- SB656933
- SB 656933
- UNII-MW2AIJ8USP
- MW2AIJ8USP
- CHEMBL2178579
- Elubrixin [USAN:INN]
- elubirixin
- Elubrixin (USAN)
- SCHEMBL1562280
- GTPL8499
- DTXSID60218962
- BDBM50398333
- DB12135
- D10332
- Elubrixin [USAN]
- ELUBRIXIN [INN]
- ELUBRIXIN [WHO-DD]
- elubrixinum
- RefChem:590725
- DTXCID10141453
- Elubrixin free base
- orb1309710
- SCHEMBL30515706
- EX-A10830
- HY-18263A
- AKOS040733091
- DA-63162
- CS-0016571
- NS00072300
- H20708
- T11179
- ELUBRIXIN TOSILATE [WHO-DD]
- SB-656933-AAA
- D10420
Look up ELUBRIXIN in the interactive SynDRA portal →